| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/07/2007 | CA2632272A1 Sulfamoyl sulfonate prodrugs |
| 06/07/2007 | CA2630438A1 Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds |
| 06/07/2007 | CA2629587A1 Prodrug er.beta.-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 06/06/2007 | EP1791821A2 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1381431B1 Aromatase inhibition to enhance implantation rate |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | EP0920446B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/06/2007 | EP0839039B2 Paroxetine controlled release compositions |
| 06/06/2007 | DE102004062182B4 Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient |
| 06/06/2007 | CN1976921A Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 06/06/2007 | CN1976902A N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 06/06/2007 | CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 06/06/2007 | CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/06/2007 | CN1973829A Process of preparing calcitonin microsphere |
| 06/06/2007 | CN1319938C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7226945 Estrogen receptor-β ligands |
| 05/31/2007 | WO2007062147A1 Crystal forms of cinacalcet hci and processes for their preparation |
| 05/31/2007 | WO2007062093A2 Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor |
| 05/31/2007 | WO2007060992A1 Agent for preventing or improving metabolic syndrome or insulin-resistance syndrome |
| 05/31/2007 | WO2006039215A3 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 05/31/2007 | US20070123512 Propionamide derivatives useful as androgen receptor modulators |
| 05/31/2007 | US20070123491 Podophyllotoxin derivatives as igf-1r inhibitors |
| 05/31/2007 | US20070122418 Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 05/31/2007 | DE102005057225A1 New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | DE102005057224A1 New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders |
| 05/31/2007 | CA2625299A1 Crystal forms of cinacalcet hci and processes for their preparation |
| 05/30/2007 | EP1790653A2 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it |
| 05/30/2007 | EP1790640A1 Novel imidazolidine derivative and use thereof |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1789433A2 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| 05/30/2007 | EP1789408A1 Androgen modulators |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1385527B1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1969839A Plant extract for treating hyperthyroidism |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318027C GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223791 Function regulator for retinoid relative receptor |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | US7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/24/2007 | WO2007057909A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies |
| 05/24/2007 | WO2007057152A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/23/2007 | EP1786408A1 Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/23/2007 | CN1965809A Sustained-release microsphere of LHRH antagonist for injection and preparation process thereof |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/18/2007 | WO2007056500A2 Compounds with activity at estrogen receptors |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007054269A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/18/2007 | WO2007031833A3 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 05/18/2007 | WO2007029086A3 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2624703A1 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111940 Peptide agonists of GLP-1 activity |
| 05/17/2007 | US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/16/2007 | EP1785142A1 Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds |
| 05/16/2007 | EP1784201A2 Physiologically active composition |
| 05/16/2007 | EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | CN1964989A Long lasting insulin derivatives and methods thereof |
| 05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
| 05/16/2007 | CN1964728A Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions |
| 05/16/2007 | CN1964703A Immediate release pharmaceutical tablets with height greater than width |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315865C Loguat leaf total dehydrocamphenilic acid and its preparation method and use |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315478C Composition for improving implantation rates after vitro fertilization and pharmaceutical use thereof |
| 05/15/2007 | US7217811 Human gene critical to fertility |
| 05/15/2007 | US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2127445C Nutrient composition |
| 05/10/2007 | WO2007052740A1 Equol level regulator |
| 05/10/2007 | WO2007051594A1 Treatment of diabetes |
| 05/10/2007 | WO2006128056A3 Novel phosphinic acid-containing thyromimetics |
| 05/10/2007 | US20070105901 Novel piperidine derivative |
| 05/10/2007 | US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070104759 Sustained release inserts; mixture of thermoplastic polyester, solvent and leuprolide acetate; prostate cancer |